Boxer Capital’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-811,627
| Closed | -$1.49M | – | 55 |
|
2024
Q3 | $1.49M | Hold |
811,627
| – | – | 0.07% | 61 |
|
2024
Q2 | $1.69M | Buy |
811,627
+602,400
| +288% | +$1.25M | 0.09% | 55 |
|
2024
Q1 | $839K | Hold |
209,227
| – | – | 0.04% | 55 |
|
2023
Q4 | $392K | Hold |
209,227
| – | – | 0.02% | 49 |
|
2023
Q3 | $349K | Hold |
209,227
| – | – | 0.02% | 70 |
|
2023
Q2 | $500K | Hold |
209,227
| – | – | 0.02% | 75 |
|
2023
Q1 | $655K | Hold |
209,227
| – | – | 0.03% | 72 |
|
2022
Q4 | $561K | Hold |
209,227
| – | – | 0.03% | 67 |
|
2022
Q3 | $619K | Hold |
209,227
| – | – | 0.03% | 68 |
|
2022
Q2 | $613K | Hold |
209,227
| – | – | 0.04% | 72 |
|
2022
Q1 | $1.07M | Hold |
209,227
| – | – | 0.05% | 71 |
|
2021
Q4 | $1.41M | Hold |
209,227
| – | – | 0.05% | 67 |
|
2021
Q3 | $1.45M | Hold |
209,227
| – | – | 0.05% | 84 |
|
2021
Q2 | $2.04M | Hold |
209,227
| – | – | 0.07% | 89 |
|
2021
Q1 | $3.29M | Hold |
209,227
| – | – | 0.11% | 77 |
|
2020
Q4 | $5.07M | Hold |
209,227
| – | – | 0.16% | 69 |
|
2020
Q3 | $3.52M | Hold |
209,227
| – | – | 0.12% | 71 |
|
2020
Q2 | $6.14M | Buy |
209,227
+9,660
| +5% | +$283K | 0.27% | 54 |
|
2020
Q1 | $4.59M | Buy |
+199,567
| New | +$4.59M | 0.31% | 47 |
|